1. Home
  2. ARMP vs ABVE Comparison

ARMP vs ABVE Comparison

Compare ARMP & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.35

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Logo Above Food Ingredients Inc. Common Stock

ABVE

Above Food Ingredients Inc. Common Stock

HOLD

Current Price

$2.99

Market Cap

108.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
ABVE
Founded
N/A
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
125.7M
108.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARMP
ABVE
Price
$7.35
$2.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
99.2K
2.5M
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,054,000.00
$213,446,206.00
Revenue This Year
$8.43
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.25
52 Week High
$16.34
$6.56

Technical Indicators

Market Signals
Indicator
ARMP
ABVE
Relative Strength Index (RSI) 65.33 52.65
Support Level $6.81 $1.84
Resistance Level $7.40 $2.47
Average True Range (ATR) 0.67 0.38
MACD -0.03 0.05
Stochastic Oscillator 89.99 85.71

Price Performance

Historical Comparison
ARMP
ABVE

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: